Developmental expression of pIgR gene in sheep mammary gland and hormonal regulation.
Secretory IgA found in external secretions are constituted by polymeric IgA (pIgA) bound to the extra-cellular part of the polymeric immunoglobulin receptor (pIgR). The receptor mediates transcytosis of pIgA across epithelial cells. The aim of the present study was to analyse the evolution of pIgR expression in the sheep mammary gland during the development of the mammary gland and to analyse its hormonal regulation. Gene expression of the pIgR was analysed in sheep mammary gland during pregnancy and lactation. By Northern Blot analysis, we observed that low levels of pIgR mRNA are expressed until day 70 of pregnancy. Accumulation of pIgR mRNA started during the third part of pregnancy and intensified 3 d after parturition to reach highest levels during established lactation (day 70). In situ hybridization analysis was used to confirm the increase in pIgR gene expression per mammary epithelial cell. In order to examine the hormonal regulation of the pIgR expression, virgin ewes were hormonally treated. Treatment with oestradiol and progesterone increased pIgR mRNA levels slightly. Subsequent addition of gluocotricoids induced a significant accumulation of pIgR mRNA in the mammary gland of the treated animals. Immunohistochemical analysis was performed to verify that the increase of pIgR mRNA level was associated with enhancement of the pIgR protein in mammary cells. No increase of pIgR mRNA levels were observed if PRL secretion was blocked by bromocryptine injections throughout the hormonal procedure. In conclusion, the present experiments suggest that the enhancement of pIgR levels during lactation result from combined effects of both prolactin and glucocorticoids.
Rincheval-Arnold
Aurore
A
Unité de Biologie Cellulaire et Moléculaire, Institut National de la Recherche Agronomique, France.
Belair
Lucette
L
Djiane
Jean
J
D000818:Animals; D015152:Blotting, Northern / Q000662:veterinary; D015342:DNA Probes; D004958:Estradiol / Q000494:pharmacology / Q000502:physiology; D005260:Female; D018507:Gene Expression Regulation, Developmental; D005938:Glucocorticoids / Q000494:pharmacology* / Q000502:physiology; D007071:Immunoglobulin A, Secretory / Q000378:metabolism; D007150:Immunohistochemistry / Q000662:veterinary; D017403:In Situ Hybridization; D007774:Lactation / Q000378:metabolism / Q000502:physiology; D008321:Mammary Glands, Animal / Q000254:growth & development / Q000378:metabolism*; D011247:Pregnancy; D011374:Progesterone / Q000494:pharmacology / Q000502:physiology; D011388:Prolactin / Q000494:pharmacology* / Q000502:physiology; D012333:RNA, Messenger / Q000187:drug effects / Q000378:metabolism; D011961:Receptors, Fc / Q000235:genetics* / Q000378:metabolism; D012635:Secretory Component / Q000235:genetics / Q000378:metabolism; D012756:Sheep / Q000235:genetics* / Q000276:immunology / Q000378:metabolism
D015342:DNA Probes; D005938:Glucocorticoids; C068317:IgA, secretory receptor; D007071:Immunoglobulin A, Secretory; D012333:RNA, Messenger; D011961:Receptors, Fc; D012635:Secretory Component; D011374:Progesterone; D004958:Estradiol; D011388:Prolactin